Long-term follow-up for breast cancer patients from GBG trials

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ETERNITY study is an international, multicenter, observational initiative designed to collect long-term safety and efficacy data from patients who participated in GBG trials for early breast cancer. This study will gather information on survival rates, late adverse events, and factors affecting quality of life, such as pregnancy and fertility. Patients will be registered after providing informed consent, and their follow-up data will be documented annually. The study aims to correlate long-term outcomes with the specific therapies received during the initial trials.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Participation and treatment in a GBG clinical trial for early breast cancer.
* Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.

Exclusion criteria:

* Participation and treatment in a non-GBG clinical trial for early breast cancer.
* Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.

Where it's running

• Universitätsklinikum Innsbruck, Klinische Abteilung f. Gynäkologie und Geburt
  Innsbruck, Triol, Austria Recruiting
• Klinikum Wels-Grieskirchen GmbH
  Wels, Upper Austria, Austria Recruiting
• MedUni Graz - Med. Universitätsklinik, Klinische Abteilung für Onkologie
  Graz, Austria Recruiting
• MedUni Graz - Universitätsklinik für Frauenheilkunde und Geburtshilfe
  Graz, Austria Recruiting
• Ordensklinikum Linz GmbH - BHS
  Linz, Austria Recruiting
• LKH Salzburg - PMU
  Salzburg, Austria Recruiting

Study contacts

• Study coordinator: Thomas Ballhausen, Dr.
• Email: eternity@gbg.de
• Phone: 0049610274800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.